Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 7 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Danstar Ferment AG is managing 12 pending office actions within the Biotechnology & Pharmaceuticals technology area. The portfolio involves 12 distinct examiners and 8 distinct art units. TEKCHAND SAIDHA is the busiest examiner for the company, currently handling 1 pending action. With 12 distinct examiners for 12 pending office actions, each pending matter is being reviewed by a unique individual.
The 8 distinct art units suggest that the company's biotechnology applications are spread across a variety of specialized technical classifications. This distribution requires the company to interact with many different USPTO units, reflecting a range of research and development activities within the pharmaceutical and biotech sectors. The presence of 12 pending office actions indicates an active prosecution pipeline. Having 12 distinct examiners means that the company's patent strategy must account for a spectrum of examiner feedback and procedural approaches. The 8 distinct art units highlight the technical breadth of the company's innovations, as their applications are being evaluated by experts in several different specialized fields.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 2 (20%) |
| Double-patenting + other | 4 (40%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAIDHA, TEKCHAND | 1 | 82.9% | +14.1% |
| SHELTON, SYNPHANE LA'SHAWN | 1 | 100.0% | +0.0% |
| HEASLEY, MEGHAN CHRISTINE | 1 | 75.2% | +34.0% |
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
| CRAIGO, BAHAR ALAWI | 1 | 47.1% | +27.3% |
| PAK, YONG D | 1 | 74.6% | +14.3% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.5% | +67.7% |
| THOMAS, TIMOTHY P | 1 | 26.3% | +38.0% |
| TURNER, FELICIA C | 1 | 26.3% | +30.1% |
| EPSTEIN, TODD MATTHEW | 1 | 60.9% | +43.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19057293 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | SAIDHA, TEKCHAND | — |
| 18832323 | RECOMBINANT EXPRESSION OF FUMONISIN ESTERASE, COMPOSITIONS AND USES THEREOF | SHELTON, SYNPHANE LA'SHAWN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16980250 | INACTIVATED YEAST AND YEAST PRODUCT FOR IMPROVING FERMENTATION YIELD | EPSTEIN, TODD MATTHEW | 88d overdue |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 49d overdue |
| 17372332 | PROCESS FOR MODULATING THE NUTRITIONAL VALUE OF WHOLE STILLAGE AND DISTILLERS PRODUCTS ASSOCIATED THERETO | TURNER, FELICIA C | 46d overdue |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | THOMAS, TIMOTHY P | 4d overdue |
| 18564236 | COMPOSITION AND METHOD FOR BALANCING IMMUNE SYSTEM AND METABOLIC FUNCTION IN HUMAN AND/OR ANIMAL SUBJECTS | SPAINE, ROBERT FRANKLIN | 27d |
| 18693766 | FORMULATIONS AND USES OF RESVERATROL | HEASLEY, MEGHAN CHRISTINE | — |
| 18546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | CRAIGO, BAHAR ALAWI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16980250 | INACTIVATED YEAST AND YEAST PRODUCT FOR IMPROVING FERMENTATION YIELD | EPSTEIN, TODD MATTHEW | 88d overdue |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 49d overdue |
| 17372332 | PROCESS FOR MODULATING THE NUTRITIONAL VALUE OF WHOLE STILLAGE AND DISTILLERS PRODUCTS ASSOCIATED THERETO | TURNER, FELICIA C | 46d overdue |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | THOMAS, TIMOTHY P | 4d overdue |
| 19057293 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | SAIDHA, TEKCHAND | — |
| 18693766 | FORMULATIONS AND USES OF RESVERATROL | HEASLEY, MEGHAN CHRISTINE | — |
| 18546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | CRAIGO, BAHAR ALAWI | — |
| 18355776 | METHODS FOR THE IMPROVEMENT OF PRODUCT YIELD AND PRODUCTION IN A MICROORGANISM THROUGH GLYCEROL RECYCLING | PAK, YONG D | — |
| Art Unit | Apps |
|---|---|
| 1652 | 3 |
| 1626 | 1 |
| 1655 | 1 |
| 1699 | 1 |
| 1653 | 1 |
| 1614 | 1 |
| 1793 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19057293 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | SAIDHA, TEKCHAND | — | §112DP | Non-Final OA | — | Pending | Feb 19, 2025 |
| 18832323 | RECOMBINANT EXPRESSION OF FUMONISIN ESTERASE, COMPOSITIONS AND USES THEREOF | SHELTON, SYNPHANE LA'SHAWN | 1652 | §112DP | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18693766 | FORMULATIONS AND USES OF RESVERATROL | HEASLEY, MEGHAN CHRISTINE | 1626 | §103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18564236 | COMPOSITION AND METHOD FOR BALANCING IMMUNE SYSTEM AND METABOLIC FUNCTION IN HUMAN AND/OR ANIMAL SUBJECTS | SPAINE, ROBERT FRANKLIN | 1655 | §101§103 | Final Rejection | 27d | Pending | Nov 27, 2023 |
| 18546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18355776 | METHODS FOR THE IMPROVEMENT OF PRODUCT YIELD AND PRODUCTION IN A MICROORGANISM THROUGH GLYCEROL RECYCLING | PAK, YONG D | 1652 | §102§103§112DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 1653 | §103§112DP | Non-Final OA | 49d overdue | Pending | Jul 12, 2023 |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | THOMAS, TIMOTHY P | 1614 | §103 | Non-Final OA | 4d overdue | Pending | Nov 24, 2021 |
| 17372332 | PROCESS FOR MODULATING THE NUTRITIONAL VALUE OF WHOLE STILLAGE AND DISTILLERS PRODUCTS ASSOCIATED THERETO | TURNER, FELICIA C | 1793 | §103 | Final Rejection | 46d overdue | Pending | Jul 09, 2021 |
| 16980250 | INACTIVATED YEAST AND YEAST PRODUCT FOR IMPROVING FERMENTATION YIELD | EPSTEIN, TODD MATTHEW | 1652 | §103§112 | Non-Final OA | 88d overdue | Pending | Sep 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial